Biomarkers of Heart Failure with Preserved and Reduced Ejection Fraction.

about

Biomarkers of Heart Failure with Preserved and Reduced Ejection Fraction.

Item

http://www.wikidata.org/entity/Q39127729

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Biomarkers of Heart Failure with Preserved and Reduced Ejection Fraction.

@en

Biomarkers of Heart Failure with Preserved and Reduced Ejection Fraction.

@nl

type

Item

label

Biomarkers of Heart Failure with Preserved and Reduced Ejection Fraction.

@en

Biomarkers of Heart Failure with Preserved and Reduced Ejection Fraction.

@nl

prefLabel

Biomarkers of Heart Failure with Preserved and Reduced Ejection Fraction.

@en

Biomarkers of Heart Failure with Preserved and Reduced Ejection Fraction.

@nl

P1476

Biomarkers of Heart Failure with Preserved and Reduced Ejection Fraction

@en

P2093

Emilia D'Elia

http://www.w3.org/2001/XMLSchema#string

Giuseppe Vergaro

http://www.w3.org/2001/XMLSchema#string

Michele Emdin

http://www.w3.org/2001/XMLSchema#string

P2860

Natriuretic peptide testing for predicting adverse events following heart failure hospitalization

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

Angiotensin-neprilysin inhibition versus enalapril in heart failure

Biomarkers in heart failure

Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure

IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review.

Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data.

P304

79-108

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/164_2016_86

http://www.w3.org/2001/XMLSchema#string

P478

243

http://www.w3.org/2001/XMLSchema#string

P50

Michele Senni

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28181009

http://www.w3.org/2001/XMLSchema#string

P921

heart failure

biomarker